<code id='AAB2E28BFE'></code><style id='AAB2E28BFE'></style>
    • <acronym id='AAB2E28BFE'></acronym>
      <center id='AAB2E28BFE'><center id='AAB2E28BFE'><tfoot id='AAB2E28BFE'></tfoot></center><abbr id='AAB2E28BFE'><dir id='AAB2E28BFE'><tfoot id='AAB2E28BFE'></tfoot><noframes id='AAB2E28BFE'>

    • <optgroup id='AAB2E28BFE'><strike id='AAB2E28BFE'><sup id='AAB2E28BFE'></sup></strike><code id='AAB2E28BFE'></code></optgroup>
        1. <b id='AAB2E28BFE'><label id='AAB2E28BFE'><select id='AAB2E28BFE'><dt id='AAB2E28BFE'><span id='AAB2E28BFE'></span></dt></select></label></b><u id='AAB2E28BFE'></u>
          <i id='AAB2E28BFE'><strike id='AAB2E28BFE'><tt id='AAB2E28BFE'><pre id='AAB2E28BFE'></pre></tt></strike></i>

          Home / entertainment / comprehensive

          comprehensive


          comprehensive

          author:leisure time    Page View:18991
          Hiram Secrist (left), who has Duchenne muscular dystrophy, with his mother, Kristen Secrist (center), and his grandmother, Terrie Jordan. Courtesy Secrist family

          In mid-July, Kristen Secrist hopped on a call with her 5-year-old son’s doctor, who had urgent news: The first gene therapy had been approved for Duchenne muscular dystrophy. Her son, Hiram, would be a perfect candidate — if, she added, they could get him dosed in time.

          The treatment was approved only for 4- and 5-year-olds. Hiram turned 6 in three weeks. 

          advertisement

          “Oh, crap,” Secrist said to herself.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In